These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30311259)

  • 1. Association of mitochondrial iron deficiency and dysfunction with idiopathic restless legs syndrome.
    Haschka D; Volani C; Stefani A; Tymoszuk P; Mitterling T; Holzknecht E; Heidbreder A; Coassin S; Sumbalova Z; Seifert M; Dichtl S; Theurl I; Gnaiger E; Kronenberg F; Frauscher B; Högl B; Weiss G
    Mov Disord; 2019 Jan; 34(1):114-123. PubMed ID: 30311259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications.
    Hornyak M; Scholz H; Kohnen R; Bengel J; Kassubek J; Trenkwalder C
    Sleep Med Rev; 2014 Apr; 18(2):153-64. PubMed ID: 23746768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restless legs syndrome.
    Venkateshiah SB; Ioachimescu OC
    Crit Care Clin; 2015 Jul; 31(3):459-72. PubMed ID: 26118915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Restless legs].
    Kinge E; Lossius MI
    Tidsskr Nor Laegeforen; 2004 Jan; 124(1):25-7. PubMed ID: 14716387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Restless legs syndrome].
    Vellieux G; d'Ortho MP
    Rev Med Interne; 2020 Apr; 41(4):258-264. PubMed ID: 32007297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome.
    Paulus W; Trenkwalder C
    Lancet Neurol; 2006 Oct; 5(10):878-86. PubMed ID: 16987735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Restless legs syndrome and periodic limb movements in sleep: pathophysiology and treatment].
    Wichniak A; Wierzbicka A; Jernajczyk W
    Neurol Neurochir Pol; 2003; 37(3):633-43. PubMed ID: 14593758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restless legs syndrome: nonpharmacologic and pharmacologic treatments.
    Winkelman JW; Allen RP; Tenzer P; Hening W
    Geriatrics; 2007 Oct; 62(10):13-6. PubMed ID: 17922563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
    Garcia-Borreguero D; Silber MH; Winkelman JW; Högl B; Bainbridge J; Buchfuhrer M; Hadjigeorgiou G; Inoue Y; Manconi M; Oertel W; Ondo W; Winkelmann J; Allen RP
    Sleep Med; 2016 May; 21():1-11. PubMed ID: 27448465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restless legs syndrome: an overview of the current understanding and management.
    Garcia-Borreguero D; Odin P; Schwarz C
    Acta Neurol Scand; 2004 May; 109(5):303-17. PubMed ID: 15080856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The restless legs syndrome can be treated with dopamine agonists].
    Aramideh M; de Weerd AW
    Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2173-7. PubMed ID: 17061425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THE RESTLESS LEGS SYNDROME (REVIEW).
    Japaridze G; Kasradze S; Maisuradze L; Popp R; Wetter T
    Georgian Med News; 2018 Dec; (285):74-81. PubMed ID: 30702074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep Medicine: Restless Legs Syndrome.
    Bollu PC; Yelam A; Thakkar MM
    Mo Med; 2018; 115(4):380-387. PubMed ID: 30228773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic Treatment of Restless Legs Syndrome.
    Lv Q; Wang X; Asakawa T; Wang XP
    Curr Neuropharmacol; 2021; 19(3):372-382. PubMed ID: 33380302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating restless legs syndrome: current pathophysiological concepts and clinical trials.
    Walther BW
    Expert Opin Investig Drugs; 2002 Apr; 11(4):501-14. PubMed ID: 11922859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine agonists for the treatment of restless legs syndrome.
    Fulda S; Wetter TC
    Expert Opin Pharmacother; 2005 Dec; 6(15):2655-66. PubMed ID: 16316304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D3 receptor agonist efficacy in restless legs syndrome.
    Casoni F; Galbiati A; Ferini-Strambi L
    Adv Pharmacol; 2019; 84():21-35. PubMed ID: 31229173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).
    Earley CJ; Connor J; Garcia-Borreguero D; Jenner P; Winkelman J; Zee PC; Allen R
    Sleep Med; 2014 Nov; 15(11):1288-301. PubMed ID: 25201131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restless legs syndrome.
    Bayard M; Avonda T; Wadzinski J
    Am Fam Physician; 2008 Jul; 78(2):235-40. PubMed ID: 18697508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical primer on restless legs syndrome: what we know, and what we don't know.
    Sethi KD; Mehta SH
    Am J Manag Care; 2012 Aug; 18(5 Suppl):S83-8. PubMed ID: 23009275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.